PMDA — authorised 25 March 2020
- Marketing authorisation holder: Sanofi K.K.
- Status: approved
🇯🇵 Lantus in Japan
PMDA authorised Lantus on 25 March 2020
Marketing authorisation
Lantus in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in Japan
Frequently asked questions
Is Lantus approved in Japan?
Yes. PMDA authorised it on 25 March 2020.
Who is the marketing authorisation holder for Lantus in Japan?
Sanofi K.K. holds the Japanese marketing authorisation.